JAMES BARRY
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
KATHRYN ARNOLD, ELI BAR, SOL BARER, SOL J BARER, SOL J. BARER, MICHAEL BERMAN, ISAAC BLECH, RAYMOND COHEN, SHANE GLEASON, ASHER HOLZER, THOMAS KESTER, THOMAS J. KESTER, MIKE LAWLESS, PETE LIGOTTI, JAMES LOUGHLIN, JAMES J. LOUGHLIN, ALAN MILINAZZO, ALAN W. MILINAZZO, OFIR PAZ, ROBERT RATINI, CAMPBELL ROGERS, GARY ROUBIN, M.D., CRAIG SHORE, MARVIN SLOSMAN, PAUL STUKA, PAUL STUKE, ANDREA TOMMASOLI, PATRICK VERTA, SCOTT R. WARD, EYAL WEINSTEIN
EXECUTIVE OFFICER
DIRECTOR
EXECUTIVE OFFICER
RAANAN AGUS, JOHN F. AIELLO, UMIT ALPTUNA, JEFFREY A. BARCLAY, JACK BUHAIN, DIRK DEGENAARS, ANN DENNISON, JOSEPH DIMARIA, RICHARD A. FRIEDMAN, CASEY FRIES, JOSEPH GORIN, ROBERT GRIFFITH, SUSAN HODGKINSON, ALAN S. KAVA, WESLEY LEPATNER, JASON LEVESQUE, GREG MINSON, CHRIS NELSON, DAVID PLUTZER, MARK PROCTOR, TUNDE REDDY, MARK G. RIEMANN, LAURIE E. SCHMIDT, GUARAV SETH, DYLAN SHERWOOD, JOSEPH SUMBERG, DAVID THOMAS, ADAM VAN DE BERGHE, MICHAEL WATTS, MITCHELL WEISS, CLAYTON WILMER, WEI YAN
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
JAMES PATRICK BARRY, PATRICK BARRY, GREG CAPPELLI, DAVID CHIOVETTI, CHRISTINA LEJA, CHRISTINA D LEJA, JOHN LEJA, JOHN A LEJA, BRAD LESHNOCK, JOHN LORD, JOHN MCCARTHY, ROBERT MCQUEEN, BRETT NOVEY, LORI RICHARDS, DANIEL ROTH, STEPHEN SCHULER, STEPHEN G SCHULER, NORAH SCOTT, TEDDY SCOTT, TEDDY C SCOTT, PATRICK UNZICKER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833]
DECLINE TO DISCLOSE
Debt
2022-06-30
D
OTHER
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833]
DECLINE TO DISCLOSE
Debt
2021-06-24
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2018-03-28
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2018-03-28
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2017-12-01
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
2016-06-13
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2016-03-21
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2013-01-03
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2012-10-24
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2012-09-27
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
2012-08-01
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2012-09-14
D
OTHER
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Debt
2012-04-05

